Scientists at The Wistar Institute have created an advanced humanized immune system mouse model that allows them to examine resistance to immune checkpoint blockade therapies in melanoma.
Archive | Health Professionals
New humanized mouse model provides insight into immunotherapy resistance
Posted in Melanoma News, Health Professionals, Of Interest
Regression may predict good prognosis in stage 1 and 2 cutaneous melanomas
Disease regression was associated with improved recurrence-free survival and overall survival among certain patients with stage 1 and 2 cutaneous melanomas, according to a study.
Posted in Melanoma News, Health Professionals, Of Interest
Philogen Announces the Completion of a Second Interim Analysis of Its Phase III Clinical Program With Nidlegy for the Treatment of Melanoma
Philogen S.p.A., a clinical-stage biotechnology company focused on antibody-based therapeutics, is pleased to announce that 50% of the expected events for the primary outcome analysis of the PIVOTAL study were reached in December 2020.
Posted in Melanoma News, Health Professionals, Clinical Trials
World first melanoma success in Australia prompts new trial
A Sydney man who was seriously ill with advanced melanoma has made a remarkable recovery after receiving a drug reserved for breast and ovarian cancer.
Posted in Melanoma News, Health Professionals, Patients, Clinical Trials, Latest News
